PROTAGONIST THERAPEUTICS, INC.

Other languages Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 09:58:43 2026-01-23 EST			5-day change	1st Jan Change
85.22 ^USD	+0.51%		+3.14%	-3.18%

01-13	Protagonist Therapeutics, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 08:15 AM
01-05	Takeda and Protagonist Announce Submission of New Drug Application for Rusfertide for Treatment of Polycythemia Vera	CI

Other languages

25-10-13	Bourse : Theon mise sur Exosens, Nexans change de DG, AstraZeneca devient Trump-compatible
25-10-13	Donald Trump ressort son bâton et sa carotte
25-07-21	Johnson & Johnson : dépôt d'une demande d'approbation aux USA dans le psoriasis

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

The best tools reserved for subscribers to boost the performance of your investments!